<DOC>
	<DOCNO>NCT02658331</DOCNO>
	<brief_summary>The aim study assess analytical clinical performance FilmArray ( FA ) BioThreat-E test ( BioFire® ) diagnosis Ebola virus disease field Guinea versus conventional molecular technique .</brief_summary>
	<brief_title>Evaluation FilmArray BioThreat-E Test</brief_title>
	<detailed_description>The study conduct `` Laboratoire des Fièvres Hémorragiques Virales '' Donka National Hospital ( Conakry , Guinea ) , Reference Laboratory Hemorrhagic Fevers Guinea . The reference base population include region Conakry Coyah . No specific invasive intervention require research protocol study interfere management patient accord ongoing practice Donka Ebola Treatment Center Coyah Ebola Treatment Center . Each participant verbally inform signing informed consent . Clinical data collect recorded via source document questionnaire - Clinical Report Form - base routine clinical data already provide laboratory accord practice . Another questionnaire submit biologist technician involve study assess practicability FilmArray technology , compare conventional technique , term time result , duration test manipulation , sense personnel safety specimen handle , overall workload day , preference lab professional . As main objective , analytical performance ( sensitivity specificity ) clinical performance ( positive negative predictive value ) FA BioThreat-E test whole blood evaluate comparison QuantiTect® Probe RT-PCR ( Qiagen ) RealStar® Filovirus Type RT-PCR Kit 1.0 ( Altona ) test perform serum . The status EVD define patient base result routine testing : - Positive patient : patient enrol study show positive result two routine PCR perform lab : QuantiTect Probe RT-PCR® RealStar® Filovirus Type RT-PCR Kit 1.0 . - Negative patient : patient enrol study show negative result two routine PCR perform lab : QuantiTect Probe RT-PCR® RealStar® Filovirus Type RT-PCR Kit 1.0 . - Equivocal patient : result show discrepancy two routine test . As secondary objective , possibility use FilmArray ( FA ) BioThreat-E test non-invasive specimen also assess . Urine saliva specimen analyze FA confirm positive case ( base routine test ) , patient able provide saliva and/or urine specimen accord health condition . This research protocol approve Guinean Ethical Committee .</detailed_description>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Hemorrhagic Fever , Ebola</mesh_term>
	<criteria>All patient , male female , old 18 , send Conakry Coyah Ebola Treatment Centers suspicion EVD accord WHO criterion , consider eligible Ebola routine diagnosis . Ability deliver write inform consent Age 18 . Inability provide consent Inability provide blood specimen require Ebola virus disease diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Ebola Virus Disease</keyword>
	<keyword>Rapid Diagnosis</keyword>
	<keyword>Point care</keyword>
	<keyword>Molecular platform</keyword>
</DOC>